Heart Disease Trial, Recruiting NCT07335510 Sponsor: Columbia University Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07335510
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with heart failure where the heart's pumping strength is significantly reduced (specifically, the heart pumps out 35% or less of its blood with each beat), with this diagnosis confirmed within the past 12 months
  • People whose heart failure symptoms currently fall into a moderate-to-severe category, or who currently have moderate symptoms but previously had more severe symptoms (confirm with trial site if unsure which category applies)
  • People whose most recent blood test result for a heart stress marker called NT-proBNP was below 1600 pg/ml, tested within the past 3 months
  • People who are already being treated with the maximum heart failure medications and devices that they are able to tolerate
  • People aged 18 years or older

Who may not be able to join:

  • People under 18 years of age
  • People who have had a heart attack, loss of consciousness, stroke, or a life-threatening heart rhythm event (including a shock from an implanted heart device) within the past 3 months
  • People whose carotid artery branching points (in the neck) are located higher up than a certain anatomical landmark near the jaw (confirm with trial site)
  • People who have a narrowing of more than 50% in a carotid artery (a major neck artery) caused by a build-up of fatty deposits
  • People who have irregular, potentially unstable fatty deposits in a carotid artery
  • People who have a condition affecting how the body automatically regulates blood pressure, or nerve damage affecting the body's automatic functions
  • People who have an uncontrolled slow heart rate that is causing symptoms
  • People with severe long-term lung disease
  • People currently receiving medications given to make the heart pump harder (inotropes)
  • People who have had a pacemaker or implanted heart rhythm device fitted within the past 3 months
  • People who have had a cardiac resynchronisation therapy (a specialised heart device) fitted within the past 6 months, or where fitting one is planned within the next 90 days
  • People who have previously had surgery, radiation treatment, or a stent placed in a specific area of the carotid artery in the neck
  • People who have had, or are being considered for, an organ transplant
  • People who have had, or are being considered for, a mechanical heart assist device implanted in the left side of the heart
  • People whose life expectancy is estimated to be less than 1 year at the time of screening
  • People who have a condition unrelated to the heart that would prevent them from completing a walking test used in this trial
  • People who are unable to meet the requirements of the trial for any reason
  • People with a known allergy to silicone or titanium

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nir Uriel, MD, Columbia University

Phone: 914-629-3121

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 March 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in peak exercise PCWP at 6 months post-titration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov